Please use this identifier to cite or link to this item:
https://doi.org/10.3389/fncel.2017.00415
DC Field | Value | |
---|---|---|
dc.title | Higher O-GlcNAc levels are associated with defects in progenitor proliferation and premature neuronal differentiation during in-vitro human embryonic cortical neurogenesis | |
dc.contributor.author | Parween, S | |
dc.contributor.author | Varghese, D.S | |
dc.contributor.author | Ardah, M.T | |
dc.contributor.author | Prabakaran, A.D | |
dc.contributor.author | Mensah-Brown, E | |
dc.contributor.author | Emerald, B.S | |
dc.contributor.author | Ansari, S.A | |
dc.date.accessioned | 2020-10-27T10:17:16Z | |
dc.date.available | 2020-10-27T10:17:16Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Parween, S, Varghese, D.S, Ardah, M.T, Prabakaran, A.D, Mensah-Brown, E, Emerald, B.S, Ansari, S.A (2017). Higher O-GlcNAc levels are associated with defects in progenitor proliferation and premature neuronal differentiation during in-vitro human embryonic cortical neurogenesis. Frontiers in Cellular Neuroscience 11 : 415. ScholarBank@NUS Repository. https://doi.org/10.3389/fncel.2017.00415 | |
dc.identifier.issn | 16625102 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/181230 | |
dc.description.abstract | The nutrient responsive O-GlcNAcylation is a dynamic post-translational protein modification found on several nucleocytoplasmic proteins. Previous studies have suggested that hyperglycemia induces the levels of total O-GlcNAcylation inside the cells. Hyperglycemia mediated increase in protein O-GlcNAcylation has been shown to be responsible for various pathologies including insulin resistance and Alzheimer’s disease. Since maternal hyperglycemia during pregnancy is associated with adverse neurodevelopmental outcomes in the offspring, it is intriguing to identify the effect of increased protein O-GlcNAcylation on embryonic neurogenesis. Herein using human embryonic stemcells (hESCs) as model, we show that increased levels of total O-GlcNAc is associated with decreased neural progenitor proliferation and premature differentiation of cortical neurons, reduced AKT phosphorylation, increased apoptosis and defects in the expression of various regulators of embryonic corticogenesis. As defects in proliferation and differentiation during neurodevelopment are common features of various neurodevelopmental disorders, increased O-GlcNAcylation could be one mechanism responsible for defective neurodevelopmental outcomes in metabolically compromised pregnancies such as diabetes. © 2017 Parween, Varghese, Ardah, Prabakaran,Mensah-Brown, Emerald and Ansari. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | 4 [4 (1,3 benzodioxol 5 yl) 5 (2 pyridinyl) 1h imidazol 2 yl]benzamide | |
dc.subject | 6 [4 (1 piperazinyl)phenyl] 3 (4 quinolinyl)pyrazolo[1,5 a]pyrimidine | |
dc.subject | beta tubulin | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | catechol methyltransferase | |
dc.subject | doublecortin | |
dc.subject | metabotropic receptor 4 | |
dc.subject | n acetylglucosamine | |
dc.subject | octamer transcription factor 4 | |
dc.subject | oxytocin receptor | |
dc.subject | protein | |
dc.subject | protein kinase B | |
dc.subject | reelin | |
dc.subject | suppressor of tumorigenicity protein 7 | |
dc.subject | T box brain 1 transcription factor | |
dc.subject | T box brain 2 transcription factor | |
dc.subject | transcription factor | |
dc.subject | transcription factor EMX2 | |
dc.subject | transcription factor FOXG1 | |
dc.subject | transcription factor FOXP2 | |
dc.subject | transcription factor NANOG | |
dc.subject | transcription factor Otx2 | |
dc.subject | transcription factor PAX6 | |
dc.subject | transcription factor POU3F2 | |
dc.subject | transcription factor Sox2 | |
dc.subject | unclassified drug | |
dc.subject | vesicular glutamate transporter 1 | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | apoptosis | |
dc.subject | Article | |
dc.subject | brain cell | |
dc.subject | cell proliferation | |
dc.subject | controlled study | |
dc.subject | embryo | |
dc.subject | gene expression | |
dc.subject | genetic transcription | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human embryonic stem cell | |
dc.subject | hyperglycemia | |
dc.subject | immunocytochemistry | |
dc.subject | in vitro study | |
dc.subject | mental disease | |
dc.subject | nerve cell differentiation | |
dc.subject | nervous system development | |
dc.subject | neural stem cell | |
dc.subject | nonhuman | |
dc.subject | phosphorylation | |
dc.subject | polyacrylamide gel electrophoresis | |
dc.subject | protein expression | |
dc.subject | protein modification | |
dc.subject | rat | |
dc.subject | real time polymerase chain reaction | |
dc.subject | RNA isolation | |
dc.subject | Western blotting | |
dc.subject | Wistar rat | |
dc.type | Article | |
dc.contributor.department | BIOCHEMISTRY | |
dc.description.doi | 10.3389/fncel.2017.00415 | |
dc.description.sourcetitle | Frontiers in Cellular Neuroscience | |
dc.description.volume | 11 | |
dc.description.page | 415 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3389_fncel_2017_00415.pdf | 3.85 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License